Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1.31M Buy
2,992
+483
+19% +$203K 0.01% 1038
2019
Q3
$1.05M Buy
2,509
+204
+9% +$83.3K 0.01% 1113
2019
Q2
$833K Buy
2,305
+63
+3% +$21.1K 0.01% 1244
2019
Q1
$718K Buy
2,242
+167
+8% +$51.3K 0.01% 1339
2018
Q4
$588K Buy
2,075
+178
+9% +$53.7K 0.01% 1286
2018
Q3
$606K Buy
1,897
+220
+13% +$70.1K 0.01% 1330
2018
Q2
$540K Sell
1,677
-315
-16% -$98.6K 0.01% 1249
2018
Q1
$544K Sell
1,992
-2,666
-57% -$706K 0.01% 1265
2017
Q4
$1.13M Buy
4,658
+257
+6% +$58.4K 0.02% 812
2017
Q3
$889K Buy
4,401
+389
+10% +$76.5K 0.01% 867
2017
Q2
$820K Buy
4,012
+2,548
+174% +$507K 0.01% 854
2017
Q1
$267K Sell
1,464
-1,047
-42% -$183K 0.01% 1461
2016
Q4
$402K Buy
2,511
+1,293
+106% +$190K 0.01% 1129
2016
Q3
$172K Sell
1,218
-328
-21% -$45.7K ﹤0.01% 1633
2016
Q2
$209K Buy
+1,546
New +$205K 0.01% 1438

Other funds holding CHE

Advisor Group's CHE Position: Q4 2019 in Review

Advisor Group increased its Chemed (CHE) stake by 19% in Q4 2019, buying an estimated $203K and bringing the position to 2,992 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #1038.

Advisor Group first reported a position in CHE in Q2 2016 and has held it in 15 quarters since. 415 funds tracked by Wall St. Rank hold CHE as of Q4 2019.

  • Advisor Group held 2,992 shares of Chemed worth $1.31M as of Q4 2019.
  • Advisor Group bought 483 Chemed shares in Q4 2019, an estimated $203K.
  • Chemed made up 0.01% of Advisor Group's portfolio in Q4 2019, its #1038 holding.
  • Advisor Group first reported a position in Chemed in Q2 2016 and has held it in 15 quarters since.
  • 415 funds tracked by Wall St. Rank held Chemed as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.